Markets

Market Nav

INCOME STATEMENT

You can view the income statement for the last 5 years.

Orchid Pharma Ltd.

Sep 15 BSE 709.55 ( -2.10 -0.30%)

Volume3830

Prev. Close
711.65

Open Price
709.05

Today's Low / High

700.00 712.00

Bid. Price (Qty.)0.00 (0)

Offer Price (Qty.)
0.00 (0)

52 Wk Low / High

603.80 1998.00

Sep 15 NSE 709.15( -1.60 -0.23%)

Volume46515

Prev. Close
710.75

Open Price
711.05

Today's Low / High

699.15 714.95

Bid Price (Qty.)0.00 (0)

Offer Price (Qty.) 0.00 (0)

52 Wk Low / High

603.80 1997.40

(₹ in Crs.)

Particulars	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
Months	12	12	12	12	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR	AR	AR	AR	AR
FaceValue	10.00	10.00	10.00	10.00	10.00


INCOME
Revenue From Operations [Net]	921.93	816.11	656.66	556.85	449.60
Other Operating Revenues	0.00	3.25	9.24	2.71	0.46
Total Operating Revenues	921.93	819.37	665.90	559.56	450.06

Other Income	27.47	30.86	19.43	9.00	15.23
Total Revenue	949.40	850.23	685.33	568.56	465.29

EXPENSES
Cost Of Materials Consumed	585.46	528.35	406.10	340.62	245.60
Purchase Of Stock-In Trade	2.61	0.00	0.00	0.00	0.00
Changes In Inventories Of FG,WIP And Stock-In Trade	-43.85	-43.89	-21.48	-27.06	-17.09
Employee Benefit Expenses	86.36	69.64	65.35	63.28	67.11
Finance Costs	14.54	16.35	32.23	32.01	51.34
Depreciation And Amortisation Expenses	34.55	33.24	54.79	87.02	108.92
Other Expenses	174.17	154.59	132.31	129.59	104.67
Total Expenses	853.84	758.29	669.29	625.46	560.54

Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	95.56	91.95	16.04	-56.90	-95.25

Exceptional Items	0.00	0.00	39.21	0.00	0.00
Profit/Loss Before Tax	95.56	91.95	55.25	-56.90	-95.25

Tax Expenses-Continued Operations
Current Tax	0.00	0.11	0.00	0.00	0.00
Deferred Tax	-0.10	-3.23	0.00	0.00	0.00
Tax For Earlier Years	-0.09	0.00	0.00	0.00	0.00
Total Tax Expenses	-0.19	-3.12	0.00	0.00	0.00
Profit/Loss After Tax And Before ExtraOrdinary Items	95.76	95.06	55.25	-56.90	-95.25

Profit/Loss From Continuing Operations	95.76	95.06	55.25	-56.90	-95.25

Profit/Loss From Discontinuing Operations	0.00	0.00	-6.78	58.47	-21.28
Net Profit/Loss From Discontinuing Operations	0.00	0.00	-6.78	58.47	-21.28
Profit/Loss For The Period	95.76	95.06	48.47	1.57	-116.53
Share Of Profit/Loss Of Associates	3.90	-2.90	-2.15	-3.52	0.00
Consolidated Profit/Loss After MI And Associates	99.66	92.17	46.32	-1.95	-116.53

OTHER INFORMATION

EARNINGS PER SHARE
Basic EPS (Rs.)	19.65	19.06	11.35	-0.48	-28.55
Diluted EPS (Rs.)	19.65	19.06	11.35	-0.48	-28.55

Particulars	Mar 25
Months	12
Source Of Info (AR = Annual Report, PR = Press Release)	AR
FaceValue	10.00

INCOME
Revenue From Operations [Net]	921.93
Other Operating Revenues	0.00
Total Operating Revenues	921.93
Other Income	27.47
Total Revenue	949.40
EXPENSES
Cost Of Materials Consumed	585.46
Purchase Of Stock-In Trade	2.61
Changes In Inventories Of FG,WIP And Stock-In Trade	-43.85
Employee Benefit Expenses	86.36
Finance Costs	14.54
Depreciation And Amortisation Expenses	34.55
Other Expenses	174.17
Total Expenses	853.84
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax	95.56
Exceptional Items	0.00
Profit/Loss Before Tax	95.56
Tax Expenses-Continued Operations
Current Tax	0.00
Deferred Tax	-0.10
Tax For Earlier Years	-0.09
Total Tax Expenses	-0.19
Profit/Loss After Tax And Before ExtraOrdinary Items	95.76
Profit/Loss From Continuing Operations	95.76
Profit/Loss From Discontinuing Operations	0.00
Net Profit/Loss From Discontinuing Operations	0.00
Profit/Loss For The Period	95.76
Share Of Profit/Loss Of Associates	3.90
Consolidated Profit/Loss After MI And Associates	99.66
OTHER INFORMATION
EARNINGS PER SHARE
Basic EPS (Rs.)	19.65
Diluted EPS (Rs.)	19.65